Inhibitory effect of recombinant BCG containing the fusion gene BFNA on EB virus-positive tumors. [PDF]
Huang S +9 more
europepmc +1 more source
Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial. [PDF]
Abarca K +16 more
europepmc +1 more source
Comparison Between Simple Batch and Fed-Batch Bioreactor Cultivation of Recombinant BCG. [PDF]
Mendes S +6 more
europepmc +1 more source
Enhanced Glycosylation Caused by Overexpression of Rv1002c in a Recombinant BCG Promotes Immune Response and Protects against Mycobacterium tuberculosis Infection. [PDF]
Weng S +7 more
europepmc +1 more source
Recombinant BCG vaccine expressing multistage antigens of Mycobacterium tuberculosis provides long-term immunity against tuberculosis in BALB/c mice. [PDF]
Fang D +9 more
europepmc +1 more source
Robust Immune Response and Protection against Lethal Pneumococcal Challenge with a Recombinant BCG-PspA-PdT Prime/Boost Scheme Administered to Neonatal Mice. [PDF]
Trentini MM +5 more
europepmc +1 more source
Mucosal recombinant BCG vaccine induces lung-resident memory macrophages and enhances trained immunity via mTORC2/HK1-mediated metabolic rewiring. [PDF]
Peng X +8 more
europepmc +1 more source
Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity. [PDF]
Soto JA +7 more
europepmc +1 more source
MHC-restricted Ag85B-specific CD8<sup>+</sup> T cells are enhanced by recombinant BCG prime and DNA boost immunization in mice. [PDF]
Komine-Aizawa S +7 more
europepmc +1 more source
Recombinant BCG With Bacterial Signaling Molecule Cyclic di-AMP as Endogenous Adjuvant Induces Elevated Immune Responses After Mycobacterium tuberculosis Infection. [PDF]
Ning H +8 more
europepmc +1 more source

